Insider Transactions in Q3 2024 at Hca Healthcare, Inc. (HCA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
8,358
-21.97%
|
$3,217,830
$385.42 P/Share
|
|
Sep 10
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,722
-26.51%
|
$5,296,692
$386.43 P/Share
|
|
Sep 10
2024
|
Michael S. Cuffe EVP and Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,080
+29.9%
|
$3,201,600
$145.24 P/Share
|
|
Aug 08
2024
|
Mike A Marks EVP and CFO |
BUY
Bona fide gift
|
Indirect |
2,237
+4.92%
|
-
|
|
Aug 08
2024
|
Mike A Marks EVP and CFO |
SELL
Bona fide gift
|
Direct |
2,237
-100.0%
|
-
|
|
Aug 08
2024
|
Samuel N Hazen CEO |
BUY
Bona fide gift
|
Indirect |
7,115
+32.2%
|
-
|
|
Aug 08
2024
|
Samuel N Hazen CEO |
SELL
Bona fide gift
|
Indirect |
7,115
-100.0%
|
-
|
|
Aug 06
2024
|
Samuel N Hazen CEO |
BUY
Bona fide gift
|
Indirect |
22,211
+47.31%
|
-
|
|
Aug 06
2024
|
Samuel N Hazen CEO |
SELL
Bona fide gift
|
Direct |
22,211
-9.44%
|
-
|
|
Aug 05
2024
|
Joseph A Sowell Iii SVP; Chief Development Officer |
BUY
Bona fide gift
|
Indirect |
13,367
+41.91%
|
-
|
|
Aug 05
2024
|
Joseph A Sowell Iii SVP; Chief Development Officer |
SELL
Bona fide gift
|
Direct |
13,367
-100.0%
|
-
|
|
Jul 31
2024
|
Timothy M Mc Manus Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,919
-12.67%
|
$1,422,597
$363.05 P/Share
|
|
Jul 31
2024
|
Timothy M Mc Manus Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+19.52%
|
$577,500
$77.13 P/Share
|
|
Jul 31
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
2,987
-24.01%
|
$1,084,281
$363.51 P/Share
|
|
Jul 29
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Open market or private sale
|
Direct |
1,864
-13.03%
|
$669,176
$359.92 P/Share
|
|
Jul 29
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,293
-27.01%
|
$1,894,894
$358.73 P/Share
|
|
Jul 29
2024
|
Kathleen M Whalen SVP & Chief Ethics Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,280
+29.7%
|
$1,200,600
$145.24 P/Share
|
|
Jul 29
2024
|
Deborah M Reiner SVP - Mktg. & Communications |
SELL
Open market or private sale
|
Direct |
3,314
-48.56%
|
$1,189,726
$359.96 P/Share
|
|
Jul 29
2024
|
Christopher F. Wyatt SVP & Controller |
SELL
Open market or private sale
|
Direct |
4,000
-9.0%
|
$1,440,000
$360.2 P/Share
|
|
Jul 25
2024
|
Christopher F. Wyatt SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
5,278
-10.61%
|
$1,857,856
$352.79 P/Share
|
|
Jul 25
2024
|
Christopher F. Wyatt SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
9,300
+15.76%
|
$939,300
$101.16 P/Share
|
|
Jul 25
2024
|
Kathryn A. Torres SVP-Payer Contracting & Align. |
SELL
Open market or private sale
|
Direct |
1,857
-9.47%
|
$659,235
$355.05 P/Share
|